(Reuters) - NEW YORK, July 23 - Schering-Plough Corp. said on Monday that second-quarter earnings rose sharply, fueled by growing demand for its Zetia and Vytorin cholesterol drugs and treatments for arthritis and allergies.
Profit increased to $517 million, or 34 cents per share, from $237 million, or 16 cents per share, a year earlier.
Read more at Reuters.com Market News
Profit increased to $517 million, or 34 cents per share, from $237 million, or 16 cents per share, a year earlier.
Read more at Reuters.com Market News
No comments:
Post a Comment